Switzerland · Delayed Price · Currency is CHF MindMaze Therapeutics Holding Company Description
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics’ neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic.
It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson’s therapy-reimagined through play.
The company was founded in 2012 and is headquartered in Geneva, Switzerland.
| Country | Switzerland |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Zachery Henderson |
Contact Details
Address: Avenue de Sécheron 15 Geneva, 1202 Switzerland | |
| Phone | 41 21 552 08 01 |
| Website | mindmazetherapeutics.com |
Stock Details
| Ticker Symbol | MMTX |
| Exchange | SIX Swiss Exchange |
| Reporting Currency | CHF |
| ISIN Number | CH1251125998 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Zachery W. Henderson | Chief Executive Officer |
| Jeremy Meinen CPA | Chief Financial Officer |
| Alexandre Capet | Chief Operating and Strategy Officer |
| Frédéric Condolo | Chief Technology Officer |